131st MAINE LEGISLATURE
		LD 2096		LR 2904(01)
	An Act to Ensure Access to Nonopioid, Nonnarcotic Medication for Acute Pain Relief
	Preliminary Fiscal Impact Statement for Original Bill
	Sponsor: Pres. Jackson of Aroostook
	Committee: Health Coverage, Insurance and Financial Services
	Fiscal Note Required: Yes
Preliminary Fiscal Impact Statement
			FY 2023-24	FY 2024-25	Projections  FY 2025-26	Projections  FY 2026-27
Net Cost (Savings)
	General Fund		$0	$20,921	$20,921	$20,921
	Highway Fund		$0	$7,721	$7,721	$7,721
Appropriations/Allocations
	General Fund		$0	$20,921	$20,921	$20,921
	Highway Fund		$0	$7,721	$7,721	$7,721
Fiscal Detail and Notes
	This bill requires the State Employee Health Plan to allow an insured person to request and gain access to a clinically appropriate nonopioid, nonnarcotic drug approved by the federal Food and Drug Administration for the treatment and management of acute pain not otherwise covered by the insured person's health plan. It is expected that this change will take effect on or after July 1, 2024. The total cost to the plan is estimated to be $46,339 in fiscal year 2024-25. The State Employee Health Plan would require General Fund appropriations of $20,921 in fiscal year 2024-25 and Highway Fund allocations of $7,721 in fiscal year 2024-25 for the state departments and agencies that pay premiums to the health plan to cover the increased costs for those two funds. The remaining costs of $17,697 in fiscal year 2024-25 will be distributed across multiple funds across state government.